Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery

Sponsor
Services Hospital, Lahore (Other)
Overall Status
Completed
CT.gov ID
NCT05714423
Collaborator
(none)
150
1
2
27
5.6

Study Details

Study Description

Brief Summary

Due to the anatomic characteristics of the lower calyx, lower pole stones are difficult to be eliminated through the ureter, even if the stones had been fragmented. Retrograde intrarenal surgery (RIRS) can be used to deal with lower pole stones of 1.0-2.0 cm, while percutaneous nephrolithotripsy (PCNL) is mainly used to deal with lower pole stones with larger diameter or when RIRS failed to resolve the stone. This study was conducted to compare mini PCNL and retrograde intrarenal surgery (RIRS) for the management of lower pole kidney stones in terms of efficacy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mini-PCNL
  • Procedure: RIRS
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
150 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outcomes in Lower Pole Kidney Stone Management Using Mini-PCNL Compared With Retrograde Intra Renal Surgery: A Randomized Controlled Trial
Actual Study Start Date :
Oct 1, 2020
Actual Primary Completion Date :
Nov 30, 2022
Actual Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mini-PCNL Group

In this group kidney stones will be treated with Mini-PCNL Surgery

Procedure: Mini-PCNL
Mini-PCNL will done as follows. A 6 Fr ureteral catheter will be introduced through cystoscopy and dye will be instilled to opacify the pelvicalyceal system. After elaborating the calyceal system through fluoroscopy, selective calyceal will be punctured and tract will be dilated using 16 F sheath. Miniature nephroscope 14 Fr will be then introduced and stones will be fragmented by holmium: YAG laser. Afterwards the collecting system will be examined through nephroscope and fluoroscopic confirmation will be done to ensure complete stone clearance. In all the cases, 6 Fr 24 cm DJ stent will be placed and if remained uneventful, the patient will be discharged on postoperative day 2 with oral antibiotics.

Active Comparator: RIRS Group

In this group kidney stones will be treated with Retrograde Intrarenal Surgery.

Procedure: RIRS
RIRS will be performed as follows. In this procedure a double J stent will be placed to dilate the calyceal system 2 weeks prior the surgery. During the procedure, cystoscopy will be done, and 0.035-inch guide wire will be placed in the pelvi-calyceal system. Ureteric access sheath of 12 Fr will be placed and with the help of digital polyscope the stone will be fragmented using Holmium: YAG laser using 220 μm fiber. DJ stent 6F 24 cm will be placed in all the cases. In uneventful surgery patient will be discharged on postoperative day 1 with oral antibiotics

Outcome Measures

Primary Outcome Measures

  1. Stone Clearance [4 weeks]

    Number of patients cleared from stones assessed by CT scan KUB

Secondary Outcome Measures

  1. Hospital Stay [1 week]

    Hospital stay will be assessed in days

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Renal stone at lower pole of size 10mm -20mm
Exclusion Criteria:
  • Patients with positive urine culture,

  • Patients with anatomical abnormalities determined by ultrasonography

  • Uncontrolled diabetes (HbA1c >9%)

  • Patients undergone previous renal surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shaikh Zayed Hospital Lahore Lahore Punjab Pakistan

Sponsors and Collaborators

  • Services Hospital, Lahore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. SamiUllah, Principal Investigator, Services Hospital, Lahore
ClinicalTrials.gov Identifier:
NCT05714423
Other Study ID Numbers:
  • s12
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 6, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. SamiUllah, Principal Investigator, Services Hospital, Lahore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2023